6 Committee comments

6 Committee comments

6.1 In assessing safety, the Committee was mindful of its previous evaluations of the large volume of evidence on uterine artery embolisation for the treatment of fibroids. It considered that the safety profile of uterine artery embolisation was unlikely to be different when used for adenomyosis (and patients with a combination of adenomyosis and fibroids dominated the published evidence).

6.2 The Committee noted that the patient commentaries reported good symptom relief following the procedure in a majority of patients but not in all. Occurrence of menopausal symptoms after the procedure was reported by some patients.

  • National Institute for Health and Care Excellence (NICE)